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ABSTRACT 
In this work an attempt was made for the preparation and evaluation of controlled release chitosan microspheres using anti-diabetes 
drug Metformin hydrochloride. The microspheres were prepared by Ionotropic gelation method using chitosan as polymer and 
Sodium Tripolyphosphate (TPP) as crosslinking agent. The compatibility of drug and polymer is analyzed by using FTIR and DSC 
method. There was no interaction detected by FTIR and DSC study. Further the prepared microspheres were evaluated for particle 
size, drug entrapment efficiency, surface morphology, drug content, drug loading and in vitro drug release. Amongst all the 
formulation batch 7 shows the best release when compared to other batch. SEM (Scanning electron microscopy) revealed that 
microspheres were spherical and porous. Finally it was concluded that Metformin hydrochloride loaded chitosan – TPP microspheres 
have been found suitable for controlled release formulation due to its bioavailability and biodegradability and thus lead to improved 
patient compliance. 
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INTRODUCTION 
Over the past 30 years, greater surveillance has been 
focused on the development of controlled release drug 
delivery system to provide uniform concentration of the 
drug at the absorption site, and diminishing not only the 
side effects but also the frequency of administration.
 1 
There are many ways for delivering a therapeutic 
substance to the target site in a controlled release 
manner. One such way is using microspheres as carriers 
for drugs.Microspheres can be defined as the structure 
made up of continuous phase of one or more miscible 
polymers in which drug particles are dispersed at the 
molecular or macroscopic level. Microspheres are small 
spherical particles, with diameters in the micrometer 
range (typically 1µm to 1000 µm).
 2
 Diabetes is one of 
the most continual and significant issue around the 
world especially Indians are genetically more prone to 
it.
 3 
Metformin hydrochloride is an oral anti- 
hyperglycemic biguanide agent used in the treatment of 
non- insulin dependent diabetes mellitus (type II 
diabetes). Metformin hydrochloride enhances glycemic 
control by improving insulin sensitivity and decreasing 
intestinal absorption of glucose.
 4 
Chitosan is most 
widely used as a carrier for various novel dosage forms 
mainly due to its characteristic to improve the solubility 
of poorly soluble drugs as well as to control the release 
of drugs by slow erosion from hydrated matrix.
5, 6 
MATERIAL AND METHODS 
Metformin hydrochloride was granted from Tidal 
Pharmaceuticals Pvt Ltd, Gowalthai. Chitosan was 
obtained from LOBA. Sodium Tripolyphosphate was 
obtained from CDH Laboratory Reagents, New Delhi. 
Preformulation Studies 
Preformulation study is the initial stepin judicious 
development of both active pharmaceutical ingredient 
(API) and drug product. A preformulation study is an 
Kalpna et al                                                                                                     Journal of Drug Delivery & Therapeutics. 2018; 8(5-s):378-387            
ISSN: 2250-1177                                                                             [379]                                                                             CODEN (USA): JDDTAO 
important mechanism for determination of physical and 
chemical properties of the drug before including it in 
formulation advancement.  Preformulation studies are 
essential treaty for progress of safe, effective, and stable 
dosage form. Thus, in order to establish supreme 
condition for clinically useful delivery system, 
preformulation studies were executed. Valuable 
pharmaceutical dosage form development requires 
various preformulation guidelines. Preformulation 
studies include solubility, melting point, and partition 
coefficient.
 7, 8
 The drug and excipient interaction studies 
were carried out by FT-IR and DSC.  
Determination of lambda max 
UV visible spectrophotometric method was used to 
gather structural information about chromophoric part of 
Metformin hydrochloride. 10 mg of the drug was 
dissolved in 10 ml and further volume made up to 100 
ml with saline phosphate buffer pH 7.4, suitable 
dilutions were made. Zero order spectra were reported in 
the range of 200-400 nm to establish absorption maxima 
of Metformin hydrochloride. 
9 
Fourier Transform Infra-Red (FT-IR) Spectroscopy 
IR spectroscopy is most effective system for qualitative 
identification of compound. The necessary information 
regarding the group present in specific compound has 
been given by IR spectroscopy. IR study was executed 
by using Perkin Elmer Fourier transformed infrared 
spectrophotometer. The potassium bromide (KBr) disk 
technique was applied using 100 mg of spectroscopic 
grade dried KBr. KBr was ground into fine powder 
using a mortar/pestle and coagulate into disc under a 
hydraulic pressure at 10,000psi. Metformin 
hydrochloride, chitosan, and drug excipient mixture 
were deposited on the KBr disc with the help of a 
capillary tube. Each KBr disc was examined at a 
resolution of 400 cm
-1
 over the wavelength region of 
4000 – 400 cm-1 and characteristics bands were 
reported. 
10
 
 Differential Scanning Calorimetry (DSC) 
To analyze any possible correlation between the drug 
and the utilized additives, DSC thermo grams of pure 
drug (Metformin hydrochloride) and drug excipient 
mixture with additives were accomplished. The samples 
of 10 mg were taken and heated in open aluminium pans 
at a heating rate of 10ºC/min in a 30ºC to 300ºC 
temperature range.
11
 
Preparation of standard curves of Metformin 
hydrochloride 
By reading the instrument (UV-visible 
spectrophotometer) at 233 nm Metformin hydrochloride 
concentration in the solution was determined. The 
standard curves of Metformin hydrochloride were 
prepared in saline phosphate buffer pH 1.2 and, pH 7.4. 
Preparation of calibration curve of Metformin 
hydrochloride at pH 1.2 
50 ml of the potassium chloride solution (0.2M) was 
placed in a 200 ml volumetric flask and 95 ml 
hydrochloric acid solution (0.2M) was added to it and 
then distilled water was added to make the volume to 
200 ml. 
Preparation of calibration curve of Metformin 
hydrochloride at pH 7.4 
50 mg of Metformin hydrochloride was correctly 
weighed and transferred into 50 ml standard flask and 
then volume was made up to 50 ml. Pipette out 0.2ml, 
0.4ml, 0.6ml, 0.8ml, and 1 ml from the above solution 
transferred into 10 ml standard flask and diluted to 10 
ml with phosphate buffer 7.4.  
Preparation of chitosan microspheres by Ionotropic 
gelation method 
In this method chitosan stock solution (1% w/v) was 
prepared by dissolving chitosan in glacial acetic acid 
(1% v/v) at room temperature. The drug Metformin 
hydrochloride (1% w/v) was dissolved directly into the 
above prepared chitosan solution. Through a disposable 
syringe needle 10 ml of this bubble free solution was 
dropped into a gently agitating 100 ml of 2% (w/v) 
sodium tripolyphosphate solution. The dropping rate and 
falling distance were kept constant. The solution was 
magnetically stirred for half an hour followed by 
filtration and rinsing with distilled water. Gel like beads 
were achieved which air was dried for 24 hours 
followed by over drying for 6 hours at 50 º C.
12 
Characterization of Metformin hydrochloride loaded 
chitosan microspheres
 
Particle size determination 
Particle size of microsphere formulations was measured 
using Zetasizer Nano Series- ZS (Malvern instrument, 
UK). Each sample was measured in triplicate and the 
average results were calculated.
13, 14, 15 
Determination of percentage yield 
The yield of microspheres was measured with concern 
to drug and polymer weight. After the preparation of 
microspheres they were collected, dried and weighed 
over electronic digital balance and the percentage yield 
was calculated by the formula
16
: 
Percentage yield (w/w)=
                           
                                 
      
Determination of drug content 
The drug content of Metformin hydrochloride was 
determined by UV spectrophotometric method. In 50ml 
phosphate buffer solution (pH 7.4) accurately weighed 
100 mg blend of microsphere and carrier was dissolved 
and absorbance was measured on UV spectrophotometer 
at 233 nm. The method is verified for linearity, accuracy 
and precision.
17 
Determination of drug loading 
Depending upon the results of drug content, drug 
loading was determined by the formula: 
Drug loading =   
                                 
                      
      
Determination of Entrapment Efficiency 
To determine entrapment efficiency firstly the chitosan 
microspheres were crushed to powder with the help of 
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mortar –pestle. 50 mg of the powder was taken for 
estimating the amount of drug absolutely present in 
microspheres. To a flask containing 10ml of 0.1 N HCl 
this powder was added for digestion for 24 hours. Later, 
the solution was filtered through Whatman filter paper 
no 4 and optical density of the filtrate was taken 
spectrophotometrically.
18
 The encapsulation efficiency 
was calculated by the following equation: 
% Encapsulation Efficiency = (Actual entrapment 
level/ Theoretical entrapment level) ×100 
In- vitro dissolution studies 
USP type II apparatus (paddle type) were operated to 
perform in –vitro dissolution studies of Metformin 
hydrochloride. By using phosphate buffer of pH (7.4) as 
dissolution medium at 37±0.5ºC with 100 rpm speed the 
dissolution studies were conducted. From the 
preparation each of samples equivalent to 100 mg of 
microsphere were added into the dissolution medium. 
Periodically (0, 0.25, 0.5, 1, 2, 3, 4, 5, 6, 8, 10 hrs)1ml 
aliquots of the sample were withdrawn and filtered 
through 0.45µ membrane filter. Every time the 
withdrawn sample was replaced with the same quantity 
of fresh dissolution medium. The filtered solutions were 
diluted suitably. By using UV spectrophotometer at 
wavelength of 233 nm the samples were examined for 
their drug content.
19 
Scanning Electron Microscope (SEM)  
Scanning electron microscope is used to attain scanning 
electron micrographs of Metformin hydrochloride 
microspheres. The instrument used for this purpose is 
Hitachi S-4800 scanning electron microscope. The 
microspheres were assembled directly on to the SEM 
sample stub, using double sided sticking tape, and 
coated with gold film (thickness 200 nm) under reduced 
pressure (0.001 torr).
20 
Stability Studies 
The main objective of stability testing is to give 
evidence on the changes of quality of drug product with 
respect to time under the influence of various 
environmental factors such as temperature, humidity, 
and light, and enables recommended storage conditions, 
re-test periods and shelf lives to be accomplished. 
According to the ICH guidelines the optimized 
formulation was kept for accelerated stability for six 
months. Microspheres were kept in stability chamber 
maintained at temperature of 
40ºC±2ºC/75%RH±5%RH. During the study period, the 
formulation was monitored at prearranged time intervals 
of 0, 15, 30, 45, 60, 75, 90, 180 days for change in 
physical appearance, drug content and in- vitro release 
characteristics. 
[21] 
RESULT AND DISCUSSION 
Preformulation Studies 
Metformin hydrochloride was found to be white 
hygroscopic crystalline powder. 
Solubility 
Metformin hydrochloride was found to be freely soluble 
in water, isopropyl alcohol, methylene chloride, slightly 
soluble in ethanol and practically insoluble in 
chloroform and acetone. 
Melting Point 
The calculated melting point of Metformin 
hydrochloride was found to be 224ºC. This result is the 
same as reported in reference and helps in the 
identification and purity of the drug powder used in the 
study. 
Partition Coefficient 
The partition coefficient of Metformin hydrochloride 
was found to be 0.062. 
Determination of absorption maxima 
Absorption maxima of metformin hydrochloride in 
phosphate buffer 7.4 were found to be 233 nm which is 
similar to the pharmacopoeial standards. 
Fourier Transform Infra-Red Spectroscopy 
The FT-IR spectrum of Metformin hydrochloride, 
chitosan and their physical mixture evidenced various 
characteristics peaks which are showed in Fig 1, Fig 2, 
and Fig 3.The spectra showed that the free Metformin 
hydrochloride and formulated Metformin hydrochloride 
were in resemblance that ratified that the obtained 
sample of Metformin hydrochloride was pure. 
 
 
Figure 1: FT-IR spectrum of Metformin hydrochloride 
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Figure 2: FT-IR spectrum of Chitosan 
 
 
Figure 3: FT-IR spectrum of Metformin hydrochloride, chitosan. 
 
Differential Scanning Calorimetry (DSC) studies 
Thermal characteristics of pure drug, polymer, and 
chitosan unloaded microspheres and chitosan drug 
loaded microspheres was examined by using DSC 
analysis which are showed in Fig 4, Fig 5, Fig 6, and Fig 
7. DSC analysis revealed that there is no interaction 
between polymer and drug. 
 
 
Figure 4: DSC thermogram of Chitosan 
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Figure 5: DSC thermogram of Metformin hydrochloride 
 
Figure 6: DSC thermogram of unloaded Chitosan microspheres 
 
Figure 7: DSC thermogram of drug loaded chitosan microspheres. 
 
Standard curve of Metformin hydrochloride insaline phosphate buffer pH 1.2 and pH 7.4. 
Standard stock solution and standard working solutions were prepared in saline phosphate buffer pH 1.2; pH 7.4 and 
standard curves were obtained by plotting the data. 
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Figure 8: Standard curve of metformin hydrochloride in 
saline phosphate buffer pH 1.2 
 
Figure 9: Standard curve of Metformin hydrochloride in 
saline phosphate buffer pH 7.4
 
Formulation and evaluation of Metformin hydrochloride loaded chitosan microspheres 
Microspheres were prepared by using ionotropic gelation method. Further the prepared microspheres were evaluated 
for particle size, percentage yield, drug content, drug loading and entrapment efficiency.  
 
Table 1: Variables for preparation of microspheres 
S. No. Conc. of 
Chitosan (%) 
Conc. of TPP 
(%) 
Stirring 
Speed (rpm) 
Stirring time 
(min.) 
Volume of 
chitosan- 
drug solution 
Result/ 
Sphericity 
1 1 0.5 600 30 10 Spherical 
2 1 1 600 30 10 Spherical 
3 1 1 800 30 10 Spherical 
4 1 1 800 30 10 Spherical 
5 1.5 2 1000 30 10 Spherical 
6 1.5 2 1000 30 10 Spherical 
7 1.5 2 1200 30 10 Spherical 
8 2 2 1200 30 10 Spherical 
9 2 3 1400 30 10 Spherical 
10 2 3 1500 30 10 Spherical 
 
Particle size determination 
Table 2:  Variables for microspheres preparation 
BATCH NO Chitosan: Metformin HCl ratio Particle size (µm) 
F1 Drug free particle 600 
F2 1:0.5 671 
F3 1:1 595 
F4 1:1.5 715 
F5 1:1.75 585 
F6 1:2 634 
F7 1:2.5 580 
F8 1:2.75 760 
F9 1:3 812 
F10 1:3.5 592 
 
The microspheres prepared under stirring speed of 1200 
rpm with chitosan concentration (1.5%) and TPP 
concentration (2%) shows best result for particle size 
that is 580 µm. The mean particle size of all the prepared 
batches of microspheres ranged between 580µm -812µm 
as listed in table 2. The batch 7 having Chitosan: 
Metformin HClratio of (1:2.5) showed least particle size 
and was used for further experiment. 
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Figure 10: Particle size of final optimized formulation 
Evaluation parameters of microspheres 
The prepared formulations were evaluated for various parameters such as percentage yield, drug content, drug loading, 
and entrapment efficiency. 
Table 3: Different evaluation parameters of microspheres 
Batch. NO. Percentage yield % Drug content (%)± 
SD 
Drug loading (%)± 
SD 
Encapsulation 
Efficiency (%) 
F1 23.9% 82.17±2.21 0.202±0.01 83.17 
F2 19.4% 76.75±4.50 0.180±0.005 77.75 
F3 23.4% 70.26±0.3 0.159±0.008 94.05 
F4 15.8% 90.31±0.04 0.153±0.002 90.31 
F5 15.2% 83.45±0.06 0.131±0.005 84.45 
F6 26.3% 78.47±0.09 0.112±0.006 80.47 
F7 26.5% 95.07±0.32 0.124±0.001 94.26 
F8 25.2% 91.96±0.10 0.103±0.003 92.96 
F9 24.8% 85.57±0.3 0.094±0.002 86.76 
F10 22.4% 84.52±0.2 0.091±0.004 94.13 
 
The maximum percentage yield, drug content, drug 
loading and entrapment efficiency was obtained from 
batch 7. An increase in the amount of polymer 
(chitosan) is mainly responsible for increase in drug 
content, drug loading, and entrapment efficiency. The 
mean particle size is directly related to the polymer 
concentration. The increase in polymer concentration is 
only the reason for increase in the particle size. From 
batch 7 the percentage yield was found to be 26.5%, 
drug content was found to be 95.07±0.32, drug loading 
was found to be 0.124±0.001 and encapsulation 
efficiency was found to be 94.26. 
In- vitro dissolution studies 
The in- vitro dissolution studies of Metformin 
hydrochloride from microspheres was examined in 
saline phosphate buffer pH 7.4. 
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Table 4: Cumulative % drug permeated from optimized formulation 
S. 
NO. 
Time 
(hours) 
F1 F2 F3 F4 F5 F6 F7 F8 F9 F10 
1 0 0 0 0 0 0 0 0 0 0 0 
2 0.25 4.5 5.5 5.21 5.74 6.01 4.98 6.27 2.75 4.69 5.49 
3 0.5 18.23 19.02 22.4 18.2 22.26 20.52 18.7 19.07 21.1 19.19 
4 1 29.36 26.09 33.24 25.52 28.46 31.99 30.84 28.05 28.99 27.69 
5 2 32.82 33.25 40.65 34.63 31.86 38.66 37.98 37.09 34.18 31.88 
6 3 36.33 38.63 46.89 39.72 34.96 45.69 48.32 42.98 39.81 36.35 
7 4 41.75 42.64 49.95 43.98 39.03 50.21 57.07 48.11 44.67 40.94 
8 5 45.65 47.36 54.06 50.48 44.25 56.59 64.2 54.8 50.92 46.09 
9 6 51.25 54.25 57.32 57.26 48.64 60.18 70.56 59.27 54.79 50.68 
10 8 56.37 59.87 65.14 63.59 56.83 67.84 81.26 66.78 61.57 58.05 
11 10 63.32 65.39 71.93 75.41 62.6 75.54 89.98 73.44 69.57 65.23 
 
 
Figure 11: In-vitro drug release profile of different chitosan microspheres 
 
Figure 12: Drug Release Kinetics of Optimized Formulation (FirstOrder Kinetics 
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Figure 13: Drug Release Kinetics of Optimized Formulation (Higuchi Model) 
 
Figure 14: Drug Release Kinetics of Optimized Formulation (Korsmeyer – Peppas Model) 
 
Scanning Electron Microscopy (SEM) 
Scanning electron microscopy revealed that the 
microspheres were spherical and porous. The surface of 
the microspheres was rough and exhibited the presence 
of pores in the drug loaded microspheres. The initial 
burst release of the drug during dissolution is mainly due 
to the presence of drug particles on the surface. Surface 
study of the microspheres after dissolution showed 
bigger pores indicating that pores are responsible for the 
drug release and the mechanism of the drug may be 
diffusion controlled. 
 
Figure15: Scanning electron microscopy of chitosan 
microspheres 
Stability studies of Metformin hydrochloride loaded 
chitosan microspheres 
Optimum microspheres were exposed to accelerated 
storage conditions, 40ºC±2ºC/75%RH±5% for six 
months according to ICH guidelines for stability testing 
of new drug substances and products. Microspheres 
were characterized for physical appearance, drug content 
and in-vitro drug release at regular intervals. There was 
no change in the physical appearance of microspheres. 
Additionally there was no great difference in the drug 
content and in vitro release characteristics of drug. Thus 
result implies good stability of the formulation. 
CONCLUSION 
This research affirmed that the controlled release of 
Metformin hydrochloride loaded chitosan microspheres 
can be attained by ionotropic gelation technique using 
chitosan as polymer. DSC and FTIR studies exposed that 
there is no interaction between the drug and polymer 
which implies that drug is congenial with polymer. The 
ten batches were evaluated for particle size, percentage 
yield, drug content, drug loading and entrapment 
efficiency. The batch 7 (B7) with the drug and polymer 
ratio (1:2.5) was considered to be superior which 
showed least particle size, and maximum percentage 
yield, drug content and entrapment efficiency and 
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prolonged release of drug. The drug release from 
microspheres was affected by various chitosan 
concentrations. Scanning Electron Microscopy (SEM) 
studies revealed that the microspheres were spherical 
and porous. The drug release was found to be in 
controlled manner from batch (B7). Therefore, it was 
concluded that Metformin hydrochloride loaded chitosan 
microspheres were found to be best in the treatment of 
diabetes with reduced dosing frequency and better 
diagnosis in a controlled release mode. 
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